The European Parliament adopted by 458 votes to 219, with 19 abstentions, a resolution objecting to the draft Commission implementing regulation approving carbendazim as an existing active substance for use in biocidal products of product-types 7 and 10.

The draft Commission implementing regulation seeks to approve carbendazim as an existing active substance for use in biocidal products of product-type 7 (film preservatives) and product-type 10 (masonry preservatives), for a period of three years.

However, Parliament considered that the draft Commission implementing regulation is not consistent with EU law, in that it is not compatible with the aim and content of Directive 98/8/EC or Regulation (EU) No 528/2012.

Furthermore, it considered, in view of:

- the hazardous properties of carbendazim,

- its environmental fate, as well as the lack of risk management measures stated in the supporting documents,

- the lack of data to decisively conclude on the absence of suitable alternatives,

- the seven-year period that has passed since the submission of the assessment reports, and

- the lack of coherence between the Commission decisions on the uses of carbendazim in product-types 7, 9 and 10,

that the draft Commission implementing regulation to approve carbendazim as an existing active substance for use in biocidal products of product-types 7 and 10, even for a short period of three years, is not proportionate in light of the unacceptable risks it poses to human health and the environment, and should have lead the Commission to the conclusion of unacceptable risks, as the use of carbendazim in a product still gives rise to concerns.

It called on the Commission to withdraw its draft implementing regulation and to submit a new draft to the committee, proposing not to approve carbendazim as an active substance for use in biocidal products of product-types 7 and 10.